THE AMERICA ONE NEWS
Aug 9, 2025  |  
0
 | Remer,MN
Sponsor:  QWIKET 
Sponsor:  QWIKET 
Sponsor:  QWIKET: Elevate your fantasy game! Interactive Sports Knowledge.
Sponsor:  QWIKET: Elevate your fantasy game! Interactive Sports Knowledge and Reasoning Support for Fantasy Sports and Betting Enthusiasts.
back  
topic

#illegals

GB News: Donald Trump sends 250 illegal migrants to Rwanda as US takes advantage of £700million scrapped UK deal
Donald Trump sends 250 illegal migrants to Rwanda as US takes advantage of £700million scrapped UK deal
Rwanda has agreed to accept 250 undocumented immigrants expelled from the U.S. as part of a deportation initiative. The arrangement allows Rwandan officials to assess arrivals, providing them with job training, healthcare, and housing support.

This agreement builds on infrastructure initially created for a failed UK deportation program. Rwanda will evaluate applicants, excluding those with serious criminal records, and those accepted can leave at any time. The program may expand beyond the initial limit if both countries agree.


#politics

Breitbart: Marlow: The Hatch Act for Jack Smith Is Not Enough; Here’s What We Must Do Next
Marlow: The Hatch Act for Jack Smith Is Not Enough; Here’s What We Must Do Next
Alex Marlow discussed Jack Smith's appointment and accountability on his podcast, questioning its constitutionality and the awareness of the Biden administration regarding Smith's role. He emphasized the need to address the situation under the Hatch Act.




#health

The Telegraph: Talk therapy can help people with lower back pain, research finds
Talk therapy can help people with lower back pain, research finds
A new therapy called Cognitive Functional Therapy (CFT) shows promise for those suffering from lower back pain, improving quality of life and reducing disability. A study with over 1,000 participants found CFT more effective than standard care, with benefits lasting up to three years.

This novel approach combines education and activity enhancement, offering hope for chronic pain sufferers where traditional treatments have limited effectiveness. The findings were published in the Lancet Rheumatology journal.